| NDC Code | 19515-897-11 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (19515-897-11) > 5 mL in 1 VIAL, MULTI-DOSE (19515-897-01) |
|---|
| Product NDC | 19515-897 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flulaval Quadrivalent |
|---|
| Proprietary Name Suffix | 2019/2020 |
|---|
| Non-Proprietary Name | Influenza Virus Vaccine |
|---|
| Dosage Form | SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20190702 |
|---|
| End Marketing Date | 20200630 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125163 |
|---|
| Manufacturer | ID Biomedical Corporation of Quebec |
|---|
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|